financetom
Business
financetom
/
Business
/
GE Vernova posts higher quarterly revenue, raises 2024 forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GE Vernova posts higher quarterly revenue, raises 2024 forecast
Jul 24, 2024 5:15 AM

July 24 (Reuters) - Power services firm GE Vernova ( GEV )

posted a rise in second-quarter revenue and raised its

full-year revenue forecast on Wednesday, backed by strong demand

for its power generation equipment.

Electric utilities across the world are looking to increase

their power generating capacity and lifting the usage of

renewable energy to meet emission goals, driving demand for

equipment suppliers such as GE Vernova ( GEV ).

Its adjusted core profit more than doubled to $524 million

during the quarter.

The company booked a 27% rise in orders in its power

segment, driven by higher orders for its gas power technology.

Its electrification revenue rose 19%, compared to a year

earlier. The company raised its full-year forecast for the

segment to the range of mid- to high-teen percentage growth,

compared with earlier forecast of a low double-digit percentage

rise.

It also expects its full-year revenue to trend towards the

higher end of its prior forecast range of $34 billion to $35

billion. Its shares rose 2.5% in premarket trading.

However, its wind orders declined by 44%, primarily due to a

large offshore wind equipment order it booked last year that was

canceled during the fourth quarter.

Elevated interest rates, equipment failures and supply chain

problems have forced many wind project cancellations in the

United States and billions of dollars in writedowns by major

developers.

A turbine blade made by GE Vernova ( GEV ) at the Vineyard wind

offshore project broke on July 13, resulting in shutdown of the

project by U.S. authorities.

GE Vernova ( GEV ), which became an independent company in April

following a three-way split of General Electric ( GE ), said its

second-quarter revenue rose 1% to $8.2 billion, compared to last

year.

Analysts on average had expected revenue of $8.26 billion,

according to LSEG data.

The company also reported two fatalities during the quarter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved